No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Klacid Biaxin

No Prescription » Prescription Drugs 9 » Klacid Biaxin

Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Klacid contains the active ingredient clarithromycin which is a type of medicine known as a macrolide antibiotic. It is used to treat infections caused by bacteria. (NB. Clarithromycin is also available without a brand name ie as the generic medicine.) Clarithromycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow replicate and increase in numbers. Clarithromycin doesnĘt directly kill the bacteria but leaves them unable to increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.Clarithromycin is a broad-spectrum antibiotic that is active against a wide variety of bacteria that cause a wide variety of infections. Clarithromycin may be used to treat infections of the upper or lower airways skin or soft tissue or ears. Clarithromycin is also used to eradicate a type of bacteria called Helicobacter pylori (H pylori) from the gut. The presence of these bacteria in the gut is associated with ulcers of the stomach and duodenum (an area of the intestine directly after the stomach). Eradicating H pylori from the gut allows peptic ulcers to heal and also helps prevent them recurring. Clarithromycin is used in combination with a proton pump inhibitor such as lansoprazole or omeprazole and the antibiotics metronidazole or amoxicillin for this purpose (triple therapy). Proton pump inhibitors reduce the production of acid in the stomach and help create an environment in the stomach in which the antibiotic can work more effectively against the bacteria. They also help the ulcer to heal.To make sure the bacteria causing an infection are susceptible to clarithromycin your doctor may take a tissue sample for example a swab from the throat or skin. Clarosip drinking straws are single use straws that each contain a single dose of clarithromycin in granules. You put the lower end of the straw into a suitable drink and then sip the drink through the straw. This disperses the granules of medicine contained in the straw and you swallow them with the drink. The straw has a white controller that moves up the straw as you drink through it. When it reaches the top of the straw this indicates that the full dose has been taken. You should take all the dose at the same time - several sips of the drink may be needed.Suitable drinks are clear fluids for example lemonades fruit juices (without pulp) tea milk or water. Hot drinks above 40?C should be avoided. Carbonated (fizzy) drinks are preferable as these can mask the sensation in the mouth caused by the granules. Full-fat milk (more than 3.5 per cent fat) milkshakes or drinks with particles should not be used as they may clog the straw. What is it used for? Bacterial infections of the lungs (lower respiratory tract) eg bronchitis pneumonia.Bacterial infections of the upper respiratory tract eg tonsillitis sinusitis pharyngitis.Bacterial infections of the skin or soft tissue.Bacterial infection of the middle ear (otitis media).Eradicating Helicobacter pylori bacteria from the gut in people with peptic ulcers.

Buy Klacid Biaxin and other Prescription Drugs 9 products online at Medstore.

Buy Online at Medstore - Click Here!

About Klacid Biaxin:

Product Type: Prescription Drugs 9

Klacid ( Biaxin Generic Clarithromycin )

Klacid (Biaxin Generic Clarithromycin)

Biaxin Generic Clarithromycin

500 mg 14 tabs 28 Tablets Biaxin Generic Clarithromycin Klacid

View more Prescription Drugs 9

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.